Sotera Health Company (SHC) Dividend History

Company News

• Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director

  Sotera Health Company, a global provider of sterilization solutions and lab services, has appointed Vincent K. Petrella as its new Lead Independent Director, effective January 2, 2025. Petrella, who has served on the company's board since 2020, brings extensive public company leadership experience and will serve as a key liaison between the board, management, and shareholders.

  GlobeNewswire Inc.
• Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?

  Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  Zacks Investment Research

  Featured Companies: ESTA
• Expert Ratings For Sotera Health

  Ratings for Sotera Health (NASDAQ:SHC) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 4 1 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 2 1 0 0 0 3M Ago 0 3 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $16.79, with a high estimate of $20.00 and a low estimate of $13.00. A decline of 2.67% from the prior average price target is evident in the current average. Investigating Analyst Ratings: An Elaborate Study An in-depth analysis of recent analyst actions unveils how financial experts perceive Sotera Health. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jason Bednar Piper Sandler Announces Neutral $13.00 - Luke Sergott Barclays Lowers Overweight $14.00 $19.00 Patrick Donnelly Citigroup Lowers Buy $16.00 $18.00 David Windley Jefferies Raises Buy $15.50 $15.00 Sean Dodge RBC Capital Maintains Outperform $20.00 - Sean Dodge RBC Capital Maintains Outperform $20.00 - Luke Sergott Barclays Raises Overweight $19.00 $17.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Sotera Health. This insight gives a snapshot of analysts' perspectives on the current state of the company. Rating: Offering insights into predictions, analysts assign qualitative ...Full story available on Benzinga.com

  Benzinga
• Sotera Health (SHC) Q1 2024 Earnings Call Transcript

  SHC earnings call for the period ending March 31, 2024.

  The Motley Fool
• How to be a contrarian stock investor: This market pro shares his secrets.

  These 3 tactics contribute to this contrarian-minded mutual fund's outperformance.

  MarketWatch

  Featured Companies: BALL BSX CCK CFR COF CZR MDGL META MSFT NVDA PNC